Montag & Caldwell, LLC Abbott Laboratories Transaction History

Montag & Caldwell, LLC

  • $490 Million
  • Q3 2024

A detailed history of Montag & Caldwell, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Montag & Caldwell, LLC holds 125,933 shares of ABT stock, worth $14.7 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares
125,933
Previous 131,753 4.42%
Holding current value
$14.7 Million
Previous $13.7 Million 4.87%
% of portfolio
2.93%
Previous 2.77%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$100.07 - $118.13 $582,407 - $687,516
-5,820 Reduced 4.42%
125,933 $14.4 Million
Q2 2024

Aug 09, 2024
SELL
$100.73 - $112.44 $3.74 Million - $4.17 Million
-37,130 Reduced 21.99%
131,753 $13.7 Million
Q1 2024

May 01, 2024
SELL
$109.52 - $120.96 $138,652 - $153,135
-1,266 Reduced 0.74%
168,883 $19.2 Million
Q4 2023

Feb 05, 2024
SELL
$90.19 - $110.4 $6.48 Million - $7.93 Million
-71,864 Reduced 29.69%
170,149 $18.7 Million
Q3 2023

Nov 03, 2023
SELL
$95.53 - $114.62 $343,048 - $411,600
-3,591 Reduced 1.46%
242,013 $23.4 Million
Q2 2023

Aug 07, 2023
SELL
$100.78 - $112.29 $162,961 - $181,572
-1,617 Reduced 0.65%
245,604 $26.8 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $21,696 - $25,538
-224 Reduced 0.09%
247,221 $25 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $1.15 Million - $1.34 Million
-12,049 Reduced 4.64%
247,445 $27.2 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $364,398 - $421,904
-3,766 Reduced 1.43%
259,494 $25.1 Million
Q2 2022

Aug 09, 2022
BUY
$102.07 - $123.37 $5.74 Million - $6.94 Million
56,257 Added 27.18%
263,260 $28.6 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $312,984 - $381,664
-2,745 Reduced 1.31%
207,003 $24.5 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $3.09 Million - $3.79 Million
-26,760 Reduced 11.31%
209,748 $29.5 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $7,116 - $7,872
-61 Reduced 0.03%
236,508 $27.9 Million
Q2 2021

Aug 11, 2021
SELL
$105.79 - $124.53 $18.2 Million - $21.5 Million
-172,393 Reduced 42.15%
236,569 $27.4 Million
Q1 2021

May 11, 2021
SELL
$108.84 - $128.23 $29.4 Million - $34.7 Million
-270,459 Reduced 39.81%
408,962 $49 Million
Q4 2020

Feb 02, 2021
BUY
$105.0 - $114.42 $8.92 Million - $9.72 Million
84,926 Added 14.29%
679,421 $74.4 Million
Q3 2020

Nov 06, 2020
SELL
$91.64 - $111.29 $1.84 Million - $2.24 Million
-20,107 Reduced 3.27%
594,495 $64.7 Million
Q2 2020

Aug 03, 2020
SELL
$76.57 - $98.0 $12.5 Million - $16 Million
-163,024 Reduced 20.96%
614,602 $56.2 Million
Q1 2020

May 01, 2020
SELL
$62.82 - $91.86 $8.44 Million - $12.3 Million
-134,409 Reduced 14.74%
777,626 $61.4 Million
Q4 2019

Feb 03, 2020
SELL
$78.51 - $87.4 $1.84 Million - $2.05 Million
-23,442 Reduced 2.51%
912,035 $79.2 Million
Q3 2019

Nov 04, 2019
SELL
$81.84 - $88.74 $15.4 Million - $16.7 Million
-188,675 Reduced 16.78%
935,477 $78.3 Million
Q2 2019

Aug 01, 2019
SELL
$72.88 - $85.0 $2.62 Million - $3.06 Million
-35,953 Reduced 3.1%
1,124,152 $94.5 Million
Q1 2019

May 01, 2019
SELL
$66.22 - $80.06 $7.13 Million - $8.62 Million
-107,653 Reduced 8.49%
1,160,105 $92.7 Million
Q4 2018

Feb 01, 2019
SELL
$65.56 - $74.27 $18.6 Million - $21.1 Million
-283,900 Reduced 18.3%
1,267,758 $91.7 Million
Q3 2018

Nov 01, 2018
BUY
$60.81 - $73.36 $9.02 Million - $10.9 Million
148,334 Added 10.57%
1,551,658 $114 Million
Q2 2018

Aug 01, 2018
SELL
$57.57 - $63.54 $12.9 Million - $14.2 Million
-223,907 Reduced 13.76%
1,403,324 $85.6 Million
Q1 2018

May 02, 2018
BUY
$56.27 - $63.62 $91.6 Million - $104 Million
1,627,231 New
1,627,231 $97.5 Million

Others Institutions Holding ABT

# of Institutions
3,198
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Montag & Caldwell, LLC Portfolio

Follow Montag & Caldwell, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag & Caldwell, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montag & Caldwell, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email